Practice guideline on ovarian tissue cryopreservation and transplantation in the prevention and treatment of iatrogenic premature ovarian insufficiency

•It is estimated that at least one million prepubertal girls and women of reproductive age in China are at risk of iatrogenic premature ovarian insufficiency every year.•It is now possible to prevent and treat iatrogenic premature ovarian insufficiency.•Ovarian tissue cryopreservation and transplant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Maturitas 2024-04, Vol.182, p.107922-107922, Article 107922
Hauptverfasser: Ruan, Xiangyan, Xu, Che, Huang, Hefeng, Xu, Binghe, Du, Juan, Cheng, Jiaojiao, Jin, Fengyu, Gu, Muqing, Kong, Weimin, Yin, Chenghong, Wu, Yurui, Tian, Qinjie, Cao, Yunxia, Wu, Ruifang, Xu, Liangzhi, Jin, Jing, Li, Yanglu, Dai, Yinmei, Ju, Rui, Ma, Fei, Wang, Gang, Wei, Wei, Huang, Xiaojun, Qin, Maoquan, Lin, Yuan, Sun, Yuan, Liu, Rong, Zhang, Wei, Li, Xiaodong, Zou, Lin, Hao, Min, Ye, Xiyang, Wang, Fuling, Wang, Yue, Hu, Zhuoying, Huang, Yanhong, Zhu, Tianyuan, Yang, Caihong, Wang, Jinping, Yang, Xiaomin, Ni, Rong, Wang, Liqun, Luo, Guangxia, Min, Aiping, Zhang, Siyou, Li, Peiling, Cheng, Linghui, Li, Lianfang, Jin, Quanfang, Shi, Dongmei, Li, Yan, Ren, Fangying, Cheng, Yanxiang, Niu, Jumin, Tian, Ying, Mueck, Alfred O.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 107922
container_issue
container_start_page 107922
container_title Maturitas
container_volume 182
creator Ruan, Xiangyan
Xu, Che
Huang, Hefeng
Xu, Binghe
Du, Juan
Cheng, Jiaojiao
Jin, Fengyu
Gu, Muqing
Kong, Weimin
Yin, Chenghong
Wu, Yurui
Tian, Qinjie
Cao, Yunxia
Wu, Ruifang
Xu, Liangzhi
Jin, Jing
Li, Yanglu
Dai, Yinmei
Ju, Rui
Ma, Fei
Wang, Gang
Wei, Wei
Huang, Xiaojun
Qin, Maoquan
Lin, Yuan
Sun, Yuan
Liu, Rong
Zhang, Wei
Li, Xiaodong
Zou, Lin
Hao, Min
Ye, Xiyang
Wang, Fuling
Wang, Yue
Hu, Zhuoying
Huang, Yanhong
Zhu, Tianyuan
Yang, Caihong
Wang, Jinping
Yang, Xiaomin
Ni, Rong
Wang, Liqun
Luo, Guangxia
Min, Aiping
Zhang, Siyou
Li, Peiling
Cheng, Linghui
Li, Lianfang
Jin, Quanfang
Shi, Dongmei
Li, Yan
Ren, Fangying
Cheng, Yanxiang
Niu, Jumin
Tian, Ying
Mueck, Alfred O.
description •It is estimated that at least one million prepubertal girls and women of reproductive age in China are at risk of iatrogenic premature ovarian insufficiency every year.•It is now possible to prevent and treat iatrogenic premature ovarian insufficiency.•Ovarian tissue cryopreservation and transplantation are the most promising methods to preserve the ovarian function and fertility for women who cannot delay radiotherapy or chemotherapy.•Cryopreservation and transplantation are no longer considered experimental technologies.•Multidisciplinary experts have been consulted to formulate this guideline. Premature ovarian insufficiency (POI) refers to the decline of ovarian function before the age of 40. POI causes a reduction in or loss of female fertility, accompanied by different degrees of menopausal symptoms, which increases the risk of chronic diseases related to early menopause and seriously affects patients' quality of life and health. It is conservatively estimated that at least one million prepubertal girls and women of reproductive age in China are at risk of iatrogenic POI caused by radiotherapy and chemotherapy every year. With the development of medical technology and the breakthrough of scientific and technological advances, preventing and treating iatrogenic POI have become possible. International and national guidelines consider cryopreserved ovarian tissue transplantation to be the most promising method of preserving the ovarian function and fertility of prepubertal girls and women of reproductive age who cannot delay radiotherapy and chemotherapy. In order to guide the clinical application of ovarian tissue cryopreservation and transplantation technology in China, the Guideline Working Group finally included 14 scientific questions and 18 recommendations through a questionnaire survey, field investigation, and consultation of a large number of Chinese and English literature databases in order to provide a reference for colleagues in clinical practice.
doi_str_mv 10.1016/j.maturitas.2024.107922
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2923914392</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378512224000173</els_id><sourcerecordid>2923914392</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-f3295d94fac7ade7e4b485d7be0d9a73531a9dcb25fb703973c79c0e55274aef3</originalsourceid><addsrcrecordid>eNqFkc1uEzEUhS0EoiHwCuAlmwn-reNlVVFAqgQLWFse-7o4ytjB9kTKk_C6OJ0SsWN1pePv-ujcg9A7SjaU0OsPu81k21xis3XDCBNdVZqxZ2hFt4oPglL6HK0IV9tBUsau0Ktad4QQSbh4ia74ljNJ-fUK_f5WrGvRAX6Yo4d9TIBzwvloS7QJt1jrDNiVUz4UqFCOtsX-bpPHrdhUD3ub2qLFjv8E3LkjpH8osG3qAs4BR9tKfoAU3Rl7jAAXr5jqHEJ0EZI7vUYvgt1XePM01-jH3cfvt5-H-6-fvtze3A9OMNKGwJmWXotgnbIeFIhRbKVXIxCvreKSU6u9G5kMoyJcK-6UdgSkZEpYCHyN3i__Hkr-NUNtZorVwb7HgjxXwzTjmgrexxqpBXUl11ogmEOJky0nQ4k5t2J25tKKObdillb65tsnk3mcwF_2_tbQgZsFgB71GKGY-ngG8LGAa8bn-F-TP2bAqFk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2923914392</pqid></control><display><type>article</type><title>Practice guideline on ovarian tissue cryopreservation and transplantation in the prevention and treatment of iatrogenic premature ovarian insufficiency</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ruan, Xiangyan ; Xu, Che ; Huang, Hefeng ; Xu, Binghe ; Du, Juan ; Cheng, Jiaojiao ; Jin, Fengyu ; Gu, Muqing ; Kong, Weimin ; Yin, Chenghong ; Wu, Yurui ; Tian, Qinjie ; Cao, Yunxia ; Wu, Ruifang ; Xu, Liangzhi ; Jin, Jing ; Li, Yanglu ; Dai, Yinmei ; Ju, Rui ; Ma, Fei ; Wang, Gang ; Wei, Wei ; Huang, Xiaojun ; Qin, Maoquan ; Lin, Yuan ; Sun, Yuan ; Liu, Rong ; Zhang, Wei ; Li, Xiaodong ; Zou, Lin ; Hao, Min ; Ye, Xiyang ; Wang, Fuling ; Wang, Yue ; Hu, Zhuoying ; Huang, Yanhong ; Zhu, Tianyuan ; Yang, Caihong ; Wang, Jinping ; Yang, Xiaomin ; Ni, Rong ; Wang, Liqun ; Luo, Guangxia ; Min, Aiping ; Zhang, Siyou ; Li, Peiling ; Cheng, Linghui ; Li, Lianfang ; Jin, Quanfang ; Shi, Dongmei ; Li, Yan ; Ren, Fangying ; Cheng, Yanxiang ; Niu, Jumin ; Tian, Ying ; Mueck, Alfred O.</creator><creatorcontrib>Ruan, Xiangyan ; Xu, Che ; Huang, Hefeng ; Xu, Binghe ; Du, Juan ; Cheng, Jiaojiao ; Jin, Fengyu ; Gu, Muqing ; Kong, Weimin ; Yin, Chenghong ; Wu, Yurui ; Tian, Qinjie ; Cao, Yunxia ; Wu, Ruifang ; Xu, Liangzhi ; Jin, Jing ; Li, Yanglu ; Dai, Yinmei ; Ju, Rui ; Ma, Fei ; Wang, Gang ; Wei, Wei ; Huang, Xiaojun ; Qin, Maoquan ; Lin, Yuan ; Sun, Yuan ; Liu, Rong ; Zhang, Wei ; Li, Xiaodong ; Zou, Lin ; Hao, Min ; Ye, Xiyang ; Wang, Fuling ; Wang, Yue ; Hu, Zhuoying ; Huang, Yanhong ; Zhu, Tianyuan ; Yang, Caihong ; Wang, Jinping ; Yang, Xiaomin ; Ni, Rong ; Wang, Liqun ; Luo, Guangxia ; Min, Aiping ; Zhang, Siyou ; Li, Peiling ; Cheng, Linghui ; Li, Lianfang ; Jin, Quanfang ; Shi, Dongmei ; Li, Yan ; Ren, Fangying ; Cheng, Yanxiang ; Niu, Jumin ; Tian, Ying ; Mueck, Alfred O.</creatorcontrib><description>•It is estimated that at least one million prepubertal girls and women of reproductive age in China are at risk of iatrogenic premature ovarian insufficiency every year.•It is now possible to prevent and treat iatrogenic premature ovarian insufficiency.•Ovarian tissue cryopreservation and transplantation are the most promising methods to preserve the ovarian function and fertility for women who cannot delay radiotherapy or chemotherapy.•Cryopreservation and transplantation are no longer considered experimental technologies.•Multidisciplinary experts have been consulted to formulate this guideline. Premature ovarian insufficiency (POI) refers to the decline of ovarian function before the age of 40. POI causes a reduction in or loss of female fertility, accompanied by different degrees of menopausal symptoms, which increases the risk of chronic diseases related to early menopause and seriously affects patients' quality of life and health. It is conservatively estimated that at least one million prepubertal girls and women of reproductive age in China are at risk of iatrogenic POI caused by radiotherapy and chemotherapy every year. With the development of medical technology and the breakthrough of scientific and technological advances, preventing and treating iatrogenic POI have become possible. International and national guidelines consider cryopreserved ovarian tissue transplantation to be the most promising method of preserving the ovarian function and fertility of prepubertal girls and women of reproductive age who cannot delay radiotherapy and chemotherapy. In order to guide the clinical application of ovarian tissue cryopreservation and transplantation technology in China, the Guideline Working Group finally included 14 scientific questions and 18 recommendations through a questionnaire survey, field investigation, and consultation of a large number of Chinese and English literature databases in order to provide a reference for colleagues in clinical practice.</description><identifier>ISSN: 0378-5122</identifier><identifier>EISSN: 1873-4111</identifier><identifier>DOI: 10.1016/j.maturitas.2024.107922</identifier><identifier>PMID: 38325136</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Cryopreservation ; Female ; Fertility Preservation ; Humans ; Iatrogenic Disease - prevention &amp; control ; Iatrogenic premature ovarian insufficiency ; Menopause, Premature ; Ovarian function and fertility preservation ; Ovarian tissue cryopreservation ; Ovarian tissue transplantation ; Practice guideline ; Prevention and treatment ; Primary Ovarian Insufficiency - etiology ; Primary Ovarian Insufficiency - prevention &amp; control ; Quality of Life</subject><ispartof>Maturitas, 2024-04, Vol.182, p.107922-107922, Article 107922</ispartof><rights>2024 The Authors</rights><rights>Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-f3295d94fac7ade7e4b485d7be0d9a73531a9dcb25fb703973c79c0e55274aef3</citedby><cites>FETCH-LOGICAL-c420t-f3295d94fac7ade7e4b485d7be0d9a73531a9dcb25fb703973c79c0e55274aef3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0378512224000173$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38325136$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ruan, Xiangyan</creatorcontrib><creatorcontrib>Xu, Che</creatorcontrib><creatorcontrib>Huang, Hefeng</creatorcontrib><creatorcontrib>Xu, Binghe</creatorcontrib><creatorcontrib>Du, Juan</creatorcontrib><creatorcontrib>Cheng, Jiaojiao</creatorcontrib><creatorcontrib>Jin, Fengyu</creatorcontrib><creatorcontrib>Gu, Muqing</creatorcontrib><creatorcontrib>Kong, Weimin</creatorcontrib><creatorcontrib>Yin, Chenghong</creatorcontrib><creatorcontrib>Wu, Yurui</creatorcontrib><creatorcontrib>Tian, Qinjie</creatorcontrib><creatorcontrib>Cao, Yunxia</creatorcontrib><creatorcontrib>Wu, Ruifang</creatorcontrib><creatorcontrib>Xu, Liangzhi</creatorcontrib><creatorcontrib>Jin, Jing</creatorcontrib><creatorcontrib>Li, Yanglu</creatorcontrib><creatorcontrib>Dai, Yinmei</creatorcontrib><creatorcontrib>Ju, Rui</creatorcontrib><creatorcontrib>Ma, Fei</creatorcontrib><creatorcontrib>Wang, Gang</creatorcontrib><creatorcontrib>Wei, Wei</creatorcontrib><creatorcontrib>Huang, Xiaojun</creatorcontrib><creatorcontrib>Qin, Maoquan</creatorcontrib><creatorcontrib>Lin, Yuan</creatorcontrib><creatorcontrib>Sun, Yuan</creatorcontrib><creatorcontrib>Liu, Rong</creatorcontrib><creatorcontrib>Zhang, Wei</creatorcontrib><creatorcontrib>Li, Xiaodong</creatorcontrib><creatorcontrib>Zou, Lin</creatorcontrib><creatorcontrib>Hao, Min</creatorcontrib><creatorcontrib>Ye, Xiyang</creatorcontrib><creatorcontrib>Wang, Fuling</creatorcontrib><creatorcontrib>Wang, Yue</creatorcontrib><creatorcontrib>Hu, Zhuoying</creatorcontrib><creatorcontrib>Huang, Yanhong</creatorcontrib><creatorcontrib>Zhu, Tianyuan</creatorcontrib><creatorcontrib>Yang, Caihong</creatorcontrib><creatorcontrib>Wang, Jinping</creatorcontrib><creatorcontrib>Yang, Xiaomin</creatorcontrib><creatorcontrib>Ni, Rong</creatorcontrib><creatorcontrib>Wang, Liqun</creatorcontrib><creatorcontrib>Luo, Guangxia</creatorcontrib><creatorcontrib>Min, Aiping</creatorcontrib><creatorcontrib>Zhang, Siyou</creatorcontrib><creatorcontrib>Li, Peiling</creatorcontrib><creatorcontrib>Cheng, Linghui</creatorcontrib><creatorcontrib>Li, Lianfang</creatorcontrib><creatorcontrib>Jin, Quanfang</creatorcontrib><creatorcontrib>Shi, Dongmei</creatorcontrib><creatorcontrib>Li, Yan</creatorcontrib><creatorcontrib>Ren, Fangying</creatorcontrib><creatorcontrib>Cheng, Yanxiang</creatorcontrib><creatorcontrib>Niu, Jumin</creatorcontrib><creatorcontrib>Tian, Ying</creatorcontrib><creatorcontrib>Mueck, Alfred O.</creatorcontrib><title>Practice guideline on ovarian tissue cryopreservation and transplantation in the prevention and treatment of iatrogenic premature ovarian insufficiency</title><title>Maturitas</title><addtitle>Maturitas</addtitle><description>•It is estimated that at least one million prepubertal girls and women of reproductive age in China are at risk of iatrogenic premature ovarian insufficiency every year.•It is now possible to prevent and treat iatrogenic premature ovarian insufficiency.•Ovarian tissue cryopreservation and transplantation are the most promising methods to preserve the ovarian function and fertility for women who cannot delay radiotherapy or chemotherapy.•Cryopreservation and transplantation are no longer considered experimental technologies.•Multidisciplinary experts have been consulted to formulate this guideline. Premature ovarian insufficiency (POI) refers to the decline of ovarian function before the age of 40. POI causes a reduction in or loss of female fertility, accompanied by different degrees of menopausal symptoms, which increases the risk of chronic diseases related to early menopause and seriously affects patients' quality of life and health. It is conservatively estimated that at least one million prepubertal girls and women of reproductive age in China are at risk of iatrogenic POI caused by radiotherapy and chemotherapy every year. With the development of medical technology and the breakthrough of scientific and technological advances, preventing and treating iatrogenic POI have become possible. International and national guidelines consider cryopreserved ovarian tissue transplantation to be the most promising method of preserving the ovarian function and fertility of prepubertal girls and women of reproductive age who cannot delay radiotherapy and chemotherapy. In order to guide the clinical application of ovarian tissue cryopreservation and transplantation technology in China, the Guideline Working Group finally included 14 scientific questions and 18 recommendations through a questionnaire survey, field investigation, and consultation of a large number of Chinese and English literature databases in order to provide a reference for colleagues in clinical practice.</description><subject>Cryopreservation</subject><subject>Female</subject><subject>Fertility Preservation</subject><subject>Humans</subject><subject>Iatrogenic Disease - prevention &amp; control</subject><subject>Iatrogenic premature ovarian insufficiency</subject><subject>Menopause, Premature</subject><subject>Ovarian function and fertility preservation</subject><subject>Ovarian tissue cryopreservation</subject><subject>Ovarian tissue transplantation</subject><subject>Practice guideline</subject><subject>Prevention and treatment</subject><subject>Primary Ovarian Insufficiency - etiology</subject><subject>Primary Ovarian Insufficiency - prevention &amp; control</subject><subject>Quality of Life</subject><issn>0378-5122</issn><issn>1873-4111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1uEzEUhS0EoiHwCuAlmwn-reNlVVFAqgQLWFse-7o4ytjB9kTKk_C6OJ0SsWN1pePv-ujcg9A7SjaU0OsPu81k21xis3XDCBNdVZqxZ2hFt4oPglL6HK0IV9tBUsau0Ktad4QQSbh4ia74ljNJ-fUK_f5WrGvRAX6Yo4d9TIBzwvloS7QJt1jrDNiVUz4UqFCOtsX-bpPHrdhUD3ub2qLFjv8E3LkjpH8osG3qAs4BR9tKfoAU3Rl7jAAXr5jqHEJ0EZI7vUYvgt1XePM01-jH3cfvt5-H-6-fvtze3A9OMNKGwJmWXotgnbIeFIhRbKVXIxCvreKSU6u9G5kMoyJcK-6UdgSkZEpYCHyN3i__Hkr-NUNtZorVwb7HgjxXwzTjmgrexxqpBXUl11ogmEOJky0nQ4k5t2J25tKKObdillb65tsnk3mcwF_2_tbQgZsFgB71GKGY-ngG8LGAa8bn-F-TP2bAqFk</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>Ruan, Xiangyan</creator><creator>Xu, Che</creator><creator>Huang, Hefeng</creator><creator>Xu, Binghe</creator><creator>Du, Juan</creator><creator>Cheng, Jiaojiao</creator><creator>Jin, Fengyu</creator><creator>Gu, Muqing</creator><creator>Kong, Weimin</creator><creator>Yin, Chenghong</creator><creator>Wu, Yurui</creator><creator>Tian, Qinjie</creator><creator>Cao, Yunxia</creator><creator>Wu, Ruifang</creator><creator>Xu, Liangzhi</creator><creator>Jin, Jing</creator><creator>Li, Yanglu</creator><creator>Dai, Yinmei</creator><creator>Ju, Rui</creator><creator>Ma, Fei</creator><creator>Wang, Gang</creator><creator>Wei, Wei</creator><creator>Huang, Xiaojun</creator><creator>Qin, Maoquan</creator><creator>Lin, Yuan</creator><creator>Sun, Yuan</creator><creator>Liu, Rong</creator><creator>Zhang, Wei</creator><creator>Li, Xiaodong</creator><creator>Zou, Lin</creator><creator>Hao, Min</creator><creator>Ye, Xiyang</creator><creator>Wang, Fuling</creator><creator>Wang, Yue</creator><creator>Hu, Zhuoying</creator><creator>Huang, Yanhong</creator><creator>Zhu, Tianyuan</creator><creator>Yang, Caihong</creator><creator>Wang, Jinping</creator><creator>Yang, Xiaomin</creator><creator>Ni, Rong</creator><creator>Wang, Liqun</creator><creator>Luo, Guangxia</creator><creator>Min, Aiping</creator><creator>Zhang, Siyou</creator><creator>Li, Peiling</creator><creator>Cheng, Linghui</creator><creator>Li, Lianfang</creator><creator>Jin, Quanfang</creator><creator>Shi, Dongmei</creator><creator>Li, Yan</creator><creator>Ren, Fangying</creator><creator>Cheng, Yanxiang</creator><creator>Niu, Jumin</creator><creator>Tian, Ying</creator><creator>Mueck, Alfred O.</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202404</creationdate><title>Practice guideline on ovarian tissue cryopreservation and transplantation in the prevention and treatment of iatrogenic premature ovarian insufficiency</title><author>Ruan, Xiangyan ; Xu, Che ; Huang, Hefeng ; Xu, Binghe ; Du, Juan ; Cheng, Jiaojiao ; Jin, Fengyu ; Gu, Muqing ; Kong, Weimin ; Yin, Chenghong ; Wu, Yurui ; Tian, Qinjie ; Cao, Yunxia ; Wu, Ruifang ; Xu, Liangzhi ; Jin, Jing ; Li, Yanglu ; Dai, Yinmei ; Ju, Rui ; Ma, Fei ; Wang, Gang ; Wei, Wei ; Huang, Xiaojun ; Qin, Maoquan ; Lin, Yuan ; Sun, Yuan ; Liu, Rong ; Zhang, Wei ; Li, Xiaodong ; Zou, Lin ; Hao, Min ; Ye, Xiyang ; Wang, Fuling ; Wang, Yue ; Hu, Zhuoying ; Huang, Yanhong ; Zhu, Tianyuan ; Yang, Caihong ; Wang, Jinping ; Yang, Xiaomin ; Ni, Rong ; Wang, Liqun ; Luo, Guangxia ; Min, Aiping ; Zhang, Siyou ; Li, Peiling ; Cheng, Linghui ; Li, Lianfang ; Jin, Quanfang ; Shi, Dongmei ; Li, Yan ; Ren, Fangying ; Cheng, Yanxiang ; Niu, Jumin ; Tian, Ying ; Mueck, Alfred O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-f3295d94fac7ade7e4b485d7be0d9a73531a9dcb25fb703973c79c0e55274aef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Cryopreservation</topic><topic>Female</topic><topic>Fertility Preservation</topic><topic>Humans</topic><topic>Iatrogenic Disease - prevention &amp; control</topic><topic>Iatrogenic premature ovarian insufficiency</topic><topic>Menopause, Premature</topic><topic>Ovarian function and fertility preservation</topic><topic>Ovarian tissue cryopreservation</topic><topic>Ovarian tissue transplantation</topic><topic>Practice guideline</topic><topic>Prevention and treatment</topic><topic>Primary Ovarian Insufficiency - etiology</topic><topic>Primary Ovarian Insufficiency - prevention &amp; control</topic><topic>Quality of Life</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ruan, Xiangyan</creatorcontrib><creatorcontrib>Xu, Che</creatorcontrib><creatorcontrib>Huang, Hefeng</creatorcontrib><creatorcontrib>Xu, Binghe</creatorcontrib><creatorcontrib>Du, Juan</creatorcontrib><creatorcontrib>Cheng, Jiaojiao</creatorcontrib><creatorcontrib>Jin, Fengyu</creatorcontrib><creatorcontrib>Gu, Muqing</creatorcontrib><creatorcontrib>Kong, Weimin</creatorcontrib><creatorcontrib>Yin, Chenghong</creatorcontrib><creatorcontrib>Wu, Yurui</creatorcontrib><creatorcontrib>Tian, Qinjie</creatorcontrib><creatorcontrib>Cao, Yunxia</creatorcontrib><creatorcontrib>Wu, Ruifang</creatorcontrib><creatorcontrib>Xu, Liangzhi</creatorcontrib><creatorcontrib>Jin, Jing</creatorcontrib><creatorcontrib>Li, Yanglu</creatorcontrib><creatorcontrib>Dai, Yinmei</creatorcontrib><creatorcontrib>Ju, Rui</creatorcontrib><creatorcontrib>Ma, Fei</creatorcontrib><creatorcontrib>Wang, Gang</creatorcontrib><creatorcontrib>Wei, Wei</creatorcontrib><creatorcontrib>Huang, Xiaojun</creatorcontrib><creatorcontrib>Qin, Maoquan</creatorcontrib><creatorcontrib>Lin, Yuan</creatorcontrib><creatorcontrib>Sun, Yuan</creatorcontrib><creatorcontrib>Liu, Rong</creatorcontrib><creatorcontrib>Zhang, Wei</creatorcontrib><creatorcontrib>Li, Xiaodong</creatorcontrib><creatorcontrib>Zou, Lin</creatorcontrib><creatorcontrib>Hao, Min</creatorcontrib><creatorcontrib>Ye, Xiyang</creatorcontrib><creatorcontrib>Wang, Fuling</creatorcontrib><creatorcontrib>Wang, Yue</creatorcontrib><creatorcontrib>Hu, Zhuoying</creatorcontrib><creatorcontrib>Huang, Yanhong</creatorcontrib><creatorcontrib>Zhu, Tianyuan</creatorcontrib><creatorcontrib>Yang, Caihong</creatorcontrib><creatorcontrib>Wang, Jinping</creatorcontrib><creatorcontrib>Yang, Xiaomin</creatorcontrib><creatorcontrib>Ni, Rong</creatorcontrib><creatorcontrib>Wang, Liqun</creatorcontrib><creatorcontrib>Luo, Guangxia</creatorcontrib><creatorcontrib>Min, Aiping</creatorcontrib><creatorcontrib>Zhang, Siyou</creatorcontrib><creatorcontrib>Li, Peiling</creatorcontrib><creatorcontrib>Cheng, Linghui</creatorcontrib><creatorcontrib>Li, Lianfang</creatorcontrib><creatorcontrib>Jin, Quanfang</creatorcontrib><creatorcontrib>Shi, Dongmei</creatorcontrib><creatorcontrib>Li, Yan</creatorcontrib><creatorcontrib>Ren, Fangying</creatorcontrib><creatorcontrib>Cheng, Yanxiang</creatorcontrib><creatorcontrib>Niu, Jumin</creatorcontrib><creatorcontrib>Tian, Ying</creatorcontrib><creatorcontrib>Mueck, Alfred O.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Maturitas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ruan, Xiangyan</au><au>Xu, Che</au><au>Huang, Hefeng</au><au>Xu, Binghe</au><au>Du, Juan</au><au>Cheng, Jiaojiao</au><au>Jin, Fengyu</au><au>Gu, Muqing</au><au>Kong, Weimin</au><au>Yin, Chenghong</au><au>Wu, Yurui</au><au>Tian, Qinjie</au><au>Cao, Yunxia</au><au>Wu, Ruifang</au><au>Xu, Liangzhi</au><au>Jin, Jing</au><au>Li, Yanglu</au><au>Dai, Yinmei</au><au>Ju, Rui</au><au>Ma, Fei</au><au>Wang, Gang</au><au>Wei, Wei</au><au>Huang, Xiaojun</au><au>Qin, Maoquan</au><au>Lin, Yuan</au><au>Sun, Yuan</au><au>Liu, Rong</au><au>Zhang, Wei</au><au>Li, Xiaodong</au><au>Zou, Lin</au><au>Hao, Min</au><au>Ye, Xiyang</au><au>Wang, Fuling</au><au>Wang, Yue</au><au>Hu, Zhuoying</au><au>Huang, Yanhong</au><au>Zhu, Tianyuan</au><au>Yang, Caihong</au><au>Wang, Jinping</au><au>Yang, Xiaomin</au><au>Ni, Rong</au><au>Wang, Liqun</au><au>Luo, Guangxia</au><au>Min, Aiping</au><au>Zhang, Siyou</au><au>Li, Peiling</au><au>Cheng, Linghui</au><au>Li, Lianfang</au><au>Jin, Quanfang</au><au>Shi, Dongmei</au><au>Li, Yan</au><au>Ren, Fangying</au><au>Cheng, Yanxiang</au><au>Niu, Jumin</au><au>Tian, Ying</au><au>Mueck, Alfred O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Practice guideline on ovarian tissue cryopreservation and transplantation in the prevention and treatment of iatrogenic premature ovarian insufficiency</atitle><jtitle>Maturitas</jtitle><addtitle>Maturitas</addtitle><date>2024-04</date><risdate>2024</risdate><volume>182</volume><spage>107922</spage><epage>107922</epage><pages>107922-107922</pages><artnum>107922</artnum><issn>0378-5122</issn><eissn>1873-4111</eissn><abstract>•It is estimated that at least one million prepubertal girls and women of reproductive age in China are at risk of iatrogenic premature ovarian insufficiency every year.•It is now possible to prevent and treat iatrogenic premature ovarian insufficiency.•Ovarian tissue cryopreservation and transplantation are the most promising methods to preserve the ovarian function and fertility for women who cannot delay radiotherapy or chemotherapy.•Cryopreservation and transplantation are no longer considered experimental technologies.•Multidisciplinary experts have been consulted to formulate this guideline. Premature ovarian insufficiency (POI) refers to the decline of ovarian function before the age of 40. POI causes a reduction in or loss of female fertility, accompanied by different degrees of menopausal symptoms, which increases the risk of chronic diseases related to early menopause and seriously affects patients' quality of life and health. It is conservatively estimated that at least one million prepubertal girls and women of reproductive age in China are at risk of iatrogenic POI caused by radiotherapy and chemotherapy every year. With the development of medical technology and the breakthrough of scientific and technological advances, preventing and treating iatrogenic POI have become possible. International and national guidelines consider cryopreserved ovarian tissue transplantation to be the most promising method of preserving the ovarian function and fertility of prepubertal girls and women of reproductive age who cannot delay radiotherapy and chemotherapy. In order to guide the clinical application of ovarian tissue cryopreservation and transplantation technology in China, the Guideline Working Group finally included 14 scientific questions and 18 recommendations through a questionnaire survey, field investigation, and consultation of a large number of Chinese and English literature databases in order to provide a reference for colleagues in clinical practice.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>38325136</pmid><doi>10.1016/j.maturitas.2024.107922</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0378-5122
ispartof Maturitas, 2024-04, Vol.182, p.107922-107922, Article 107922
issn 0378-5122
1873-4111
language eng
recordid cdi_proquest_miscellaneous_2923914392
source MEDLINE; Elsevier ScienceDirect Journals
subjects Cryopreservation
Female
Fertility Preservation
Humans
Iatrogenic Disease - prevention & control
Iatrogenic premature ovarian insufficiency
Menopause, Premature
Ovarian function and fertility preservation
Ovarian tissue cryopreservation
Ovarian tissue transplantation
Practice guideline
Prevention and treatment
Primary Ovarian Insufficiency - etiology
Primary Ovarian Insufficiency - prevention & control
Quality of Life
title Practice guideline on ovarian tissue cryopreservation and transplantation in the prevention and treatment of iatrogenic premature ovarian insufficiency
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T23%3A59%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Practice%20guideline%20on%20ovarian%20tissue%20cryopreservation%20and%20transplantation%20in%20the%20prevention%20and%20treatment%20of%20iatrogenic%20premature%20ovarian%20insufficiency&rft.jtitle=Maturitas&rft.au=Ruan,%20Xiangyan&rft.date=2024-04&rft.volume=182&rft.spage=107922&rft.epage=107922&rft.pages=107922-107922&rft.artnum=107922&rft.issn=0378-5122&rft.eissn=1873-4111&rft_id=info:doi/10.1016/j.maturitas.2024.107922&rft_dat=%3Cproquest_cross%3E2923914392%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2923914392&rft_id=info:pmid/38325136&rft_els_id=S0378512224000173&rfr_iscdi=true